avian
influenza
ai
major
zoonot
viral
diseas
caus
signific
advers
impact
poultri
product
global
trade
public
health
despit
decad
research
control
effort
incid
sever
ai
outbreak
allevi
rather
increas
strategi
current
employ
control
ai
focus
prevent
viru
introduct
maintain
strict
biosecur
procedur
howev
current
biosecur
system
repeatedli
fail
protect
poultri
farm
introduct
novel
strain
continu
caus
major
outbreak
overcom
challeng
countri
incorpor
vaccin
inactiv
influenza
vaccin
iiv
control
program
unit
state
use
stamp
primari
control
strategi
occurr
recent
highli
pathogen
avian
influenza
hpai
outbreak
prove
limit
stamp
combin
biosecur
control
reason
vaccin
serious
consid
ad
countri
ai
control
arsen
iiv
current
use
countri
like
bangladesh
china
egypt
indonesia
viet
nam
hpai
virus
endem
unfortun
although
iiv
provid
good
protect
homolog
field
strain
weak
heterolog
strain
aris
random
genet
mutat
protect
heterosubtyp
strain
addit
narrow
rang
protect
seriou
concern
longterm
use
iiv
without
erad
heterolog
mismatch
strain
may
result
select
antigen
diverg
strain
live
vaccin
numer
advantag
iiv
exploit
develop
new
broadli
protect
vaccin
vaccin
regimen
sinc
live
agent
mimic
natur
infect
elicit
broad
rang
immun
respons
includ
humor
cellmedi
mucos
immun
importantli
live
vaccin
directli
administ
mucos
surfac
spray
drink
water
elicit
local
mucos
immun
also
significantli
reduc
cost
mass
administr
current
live
influenza
vaccin
avail
use
poultri
industri
live
viralvector
vaccin
live
viralvector
vaccin
induc
broader
rang
protect
compar
iiv
sever
shortcom
includ
reduc
efficaci
due
preexist
immun
viral
vector
difficulti
express
two
influenza
viru
protein
vector
liveattenu
influenza
vaccin
laiv
excel
altern
vector
vaccin
iiv
sinc
contain
protein
natur
found
influenza
viru
particl
human
laiv
use
decad
report
protect
young
individu
better
iiv
importantli
recent
studi
show
laiv
presensit
popul
subsequ
synergist
boost
efficaci
iiv
note
use
laiv
poultri
requir
strict
safeti
standard
due
concern
possibl
wild
type
strain
may
circul
domest
poultri
without
appar
clinic
symptom
undergo
genet
reassort
vaccin
viru
produc
novel
virul
strain
ideal
poultri
laiv
abl
revert
wild
type
viru
undergo
reassort
field
strain
one
promis
candid
poultri
laiv
influenza
viru
mutant
express
ctermin
truncat
nonstructur
protein
protein
due
larg
intern
delet
nt
ns
gene
segment
caus
shift
open
read
frame
prematur
stop
codon
truncat
amino
acid
mean
easili
revert
wild
type
phenotyp
two
independ
vaccin
studi
demonstr
attenu
transmit
chicken
chicken
interestingli
even
though
replic
effici
young
bird
abl
induc
robust
adapt
immun
respons
provid
protect
heterolog
viru
infect
avail
evid
suggest
high
level
immunogen
despit
poor
replic
chicken
due
defici
antagon
induct
signal
pathway
type
interferon
ifn
influenza
known
block
type
ifn
respons
creat
environ
favor
viru
replic
truncat
lead
increas
type
ifn
product
attenu
viru
anim
previous
show
infect
result
induct
high
level
type
ifn
product
avian
cell
vitro
although
unabl
detect
gene
upregul
vaccin
bird
strong
correl
interferon
stimul
gene
isg
upregul
acceler
serum
antibodi
respons
induct
high
level
protect
heterolog
viru
chicken
studi
oral
administr
recombin
chicken
shown
mimic
induc
rapid
serum
antibodi
respons
iiv
vaccin
enhanc
isg
respons
suggest
efficaci
depend
stimul
type
ifn
system
vaccin
host
similar
effect
report
meng
et
al
studi
oral
treatment
recombin
chicken
result
induct
isg
transcript
inhibit
influenza
viru
replic
chicken
live
vaccin
efficaci
inactiv
vaccin
young
immunolog
immatur
chicken
demonstr
singl
vaccin
highli
immunogen
protect
weeksold
chicken
base
previou
find
current
studi
conduct
compar
perform
hereinaft
refer
laiv
iiv
young
chicken
vaccin
day
age
although
perform
laiv
better
iiv
adapt
immun
respons
appear
depend
type
vaccin
neither
vaccin
could
provid
full
protect
heterolog
challeng
viru
subsequ
design
evalu
vaccin
regimen
bird
prime
laiv
boostvaccin
iiv
day
week
age
respect
primeboost
induc
robust
mucos
antibodi
respons
also
led
acceler
seroconvers
synergist
increas
serum
antibodi
titer
increas
antibodi
crossreact
heterolog
antigen
full
protect
heterolog
challeng
viru
experiment
anim
handl
previous
describ
anim
maintain
vaccin
challeng
euthan
accord
protocol
approv
ohio
state
univers
institut
anim
care
use
committe
iacuc
protocol
compli
us
anim
welfar
act
guid
care
use
laboratori
anim
public
health
servic
polici
human
care
use
laboratori
anim
ohio
state
univers
accredit
associ
assess
accredit
laboratori
anim
care
intern
aaalac
white
leghorn
chicken
obtain
institut
food
anim
health
research
program
wooster
oh
specif
pathogen
free
spf
flock
chicken
hous
facil
forc
air
ventil
adequ
air
exchang
prevent
ammonia
build
air
enter
leav
facil
hepa
filter
bird
kept
larg
cage
sq
inch
infect
transfer
model
isol
sq
inch
feder
design
inc
comer
ga
number
bird
cage
calcul
base
age
space
avail
subtract
space
occupi
feeder
water
system
room
isol
temperatur
maintain
bird
ad
libitum
access
feed
water
wellb
health
statu
anim
monitor
twice
daili
throughout
experi
anim
human
euthan
display
symptom
ruffl
feather
reluct
move
move
prod
respiratori
distress
injuri
relat
experiment
treatment
euthanasia
actual
exposur
carbon
dioxid
base
age
bodi
size
anim
place
euthanasia
chamber
connect
sourc
flow
set
displac
chamber
volumeminut
bird
observ
respiratori
arrest
flow
maintain
least
one
minut
arrest
observ
anim
check
absenc
breath
lack
heartbeat
respir
heartbeat
detect
anim
place
back
chamber
addit
administ
describ
death
confirm
addit
secondari
physic
euthanasia
cervic
disloc
remov
vital
organ
perform
collect
tissu
carcass
dispos
design
studi
summar
tabl
briefli
fiftyfour
bird
split
three
group
laiv
iiv
unvaccin
n
bird
per
group
bird
laiv
group
intranas
vaccin
dose
vaccin
viru
dilut
phosphatebuff
salin
pb
final
volum
iiv
group
receiv
mixtur
iiv
prepar
stock
parent
viru
titer
hemagglutin
unit
hau
montanid
isa
adjuv
seppic
franc
iiv
adjuv
vv
via
subcutan
rout
infecti
titer
live
stock
use
iiv
prepar
inactiv
betapropiolacton
use
inactiv
viru
iiv
prepar
previous
describ
unvaccin
control
group
receiv
treatment
although
mockadjuv
group
includ
studi
data
gener
previou
experi
suggest
isa
adjuv
nonspecif
antivir
effect
sinc
level
challeng
viru
shed
without
adjuv
within
rang
bird
monitor
clinic
symptom
behavior
chang
throughout
studi
day
postvaccin
dpv
five
bird
group
euthan
collect
trachea
spleen
sampl
use
transcript
analysi
describ
dpv
bird
randomli
select
group
serum
tear
sampl
collect
measur
system
mucos
antibodi
respons
respect
serum
tear
collect
bird
intranas
challeng
dose
heterolog
viru
volum
viru
use
previou
studi
share
amino
acid
sequenc
similar
protein
wildtyp
viru
mutant
day
postchalleng
dpc
six
seven
bird
group
euthan
harvest
tracheal
tissu
titrat
challeng
viru
titer
real
time
rtpcr
previous
describ
eight
differ
vaccin
regimen
test
second
experi
summar
tabl
n
per
group
three
categori
vaccin
regimen
investig
unvaccin
singl
dose
group
laiv
iiv
laiv
iiv
primeboost
group
laivlaiv
laiviiv
iiviiv
unvaccin
control
group
receiv
treatment
singl
vaccin
group
vaccin
either
day
laiv
iiv
week
laiv
iiv
age
primeboost
group
laivlaiv
laiviiv
iiviiv
receiv
prime
boost
vaccin
day
week
age
respect
vaccin
administr
conduct
describ
studi
bird
bled
week
age
measur
postvaccin
serum
antibodi
titer
tear
collect
week
age
measur
postvaccin
mucos
antibodi
respons
bird
challeng
viru
describ
level
challeng
viru
replic
monitor
real
time
rtpcr
titrat
tracheal
swab
sampl
collect
dpc
trachea
spleen
sampl
homogen
trizol
reagent
total
rna
extract
previous
describ
messeng
rna
mrna
select
convert
cdna
use
rtpcr
oligo
dt
primer
subject
quantit
pcr
use
sybr
green
system
quanta
gaithersburg
md
usa
primer
sequenc
use
amplif
oa
mx
ifn
gene
previous
publish
method
use
determin
differenti
gene
regul
use
gapdh
gene
intern
control
gene
express
level
calcul
fold
chang
unvaccin
control
group
previous
describ
analysi
serum
antibodi
chicken
bled
via
wing
vein
blood
incub
overnight
room
temperatur
serum
separ
occur
separ
sera
heat
inactiv
store
use
hemagglutin
inhibit
hi
test
hi
test
conduct
accord
recommend
world
organ
anim
health
oie
briefli
heat
inactiv
serum
serial
dilut
mix
equal
volum
antigen
prepar
contain
hau
viru
serumantigen
mixtur
incub
min
room
temperatur
form
antigenantibodi
complex
turkey
erythrocyt
suspens
ad
well
hi
titer
reciproc
determin
endpoint
dilut
show
complet
inhibit
hemagglutin
bird
consid
seroconvert
serum
show
hi
activ
dilut
higher
determin
crossreact
serum
homolog
heterolog
antigen
cross
hi
test
conduct
live
betapropiolactoneinactiv
viru
crossmatch
antisera
produc
vaccin
inactiv
antigen
live
viru
infect
base
cross
hi
titer
percent
antigen
related
calcul
previous
describ
archetti
horsfal
mucos
antibodi
respons
measur
use
tear
sampl
collect
accord
previous
describ
method
slight
modif
briefli
chicken
comfort
held
eyelid
open
fine
sodium
chlorid
crystal
less
sprinkl
onto
eye
lachrym
induc
tear
care
harvest
use
micropipett
attach
steril
tip
immedi
place
tube
consist
prevent
antibodi
dilut
first
inducedtear
collect
tear
sampl
store
use
enzymelink
immunosorb
assay
elisa
tear
sampl
dilut
factor
use
three
differ
elisa
kit
use
detect
antibodi
tear
influenza
nucleoprotein
np
specif
antibodi
measur
use
competit
elisa
kit
influenza
np
antibodi
inhibitor
elisa
virusi
corpor
sykesvil
md
usa
accord
instruct
provid
manufactur
np
reduct
index
npri
valu
calcul
base
follow
formula
npri
absorb
valu
ab
ab
valu
diluent
control
mean
ab
unvaccin
control
tear
sampl
mean
ab
valu
diluent
control
influenza
virusspecif
igg
respons
measur
indirect
elisa
kit
idexx
ai
ab
test
idexx
laboratori
westbrook
usa
accord
manufactur
instruct
influenza
virusspecif
iga
respons
measur
use
kit
describ
igg
except
secondari
antibodi
replac
fold
dilut
hrplabel
antichicken
iga
chain
specif
gallu
immunotech
inc
fergu
canada
level
igg
iga
repres
raw
od
valu
avid
index
measur
previous
describ
use
end
point
elisa
briefli
well
microtit
plate
nunc
thermo
fisher
scientif
rochest
ny
usa
coat
purifi
whole
inactiv
viru
overnight
follow
day
plate
warm
room
temperatur
hour
point
onward
manipul
done
room
temperatur
well
block
nonfat
dri
milk
pb
hour
wash
pb
two
set
serial
dilut
sera
ad
incub
hour
wash
three
time
one
set
sampl
treat
urea
hour
set
incub
pb
contain
tween
plate
wash
three
time
follow
addit
goat
antichicken
hors
reddish
peroxidas
hrp
label
igg
kpl
gaithersburg
md
usa
secondari
antibodi
well
incub
hour
plate
wash
six
time
substrat
tetramethylbenzidin
peroxidas
tmb
kpl
ad
incub
minut
reaction
stop
phosphor
acid
plate
read
nm
imark
elisa
reader
biorad
life
scienc
research
hercul
ca
usa
od
valu
dilut
right
start
linear
phase
titrat
curv
without
urea
treatment
chosen
avid
index
avid
index
defin
od
urea
treatment
od
without
urea
differ
viru
antibodi
titer
among
group
determin
oneway
anova
follow
posthoc
tukey
test
group
group
comparison
graphpad
softwar
version
san
diego
ca
usa
transcript
analysi
studi
mannwhitney
u
test
graphpad
softwar
version
use
detect
statist
differ
fold
chang
among
group
abil
laiv
iiv
stimul
innat
immun
respons
chicken
assess
quantif
mrna
transcript
level
type
iii
ifn
isg
fig
show
upregul
downregul
gene
fold
chang
unvaccin
control
group
consist
appar
chang
observ
isg
oa
mx
gene
vaccin
abl
induc
signific
upregul
oa
dpv
trachea
spleen
tissu
fig
howev
signific
differ
two
vaccin
group
despit
lower
magnitud
upregul
iiv
group
compar
laiv
group
transcript
mx
gene
also
significantli
increas
laiv
trachea
time
point
spleen
dpv
induct
mx
gene
iiv
vaccin
observ
dpv
tracheal
sampl
fig
bird
receiv
laiv
signific
decreas
mrna
level
time
point
spleen
wherea
vaccin
iiv
downregul
level
transcript
trachea
dpv
dpv
respect
transcript
spleen
dpv
even
though
level
oa
gene
transcript
consist
elev
dpv
trachea
spleen
sampl
kind
vaccin
result
dpv
spleen
sampl
show
signific
downregul
oa
gene
transcript
induc
iiv
vaccin
overal
isg
transcript
upregul
type
tissu
dpv
reduc
downregul
dpv
subtl
chang
ifn
gene
transcript
gener
trend
downregul
trachea
dpv
spleen
dpv
kind
vaccin
poor
induc
serum
antibodi
respons
chicken
seroconvers
homolog
viru
observ
eight
ten
bird
iiv
group
four
ten
bird
laiv
group
heterolog
hi
antibodi
detect
group
fig
level
antibodi
tear
sampl
measur
use
three
kind
elisa
kit
detect
antiinfluenza
nucleoprotein
np
antibodi
bind
activ
presenc
influenza
specif
chicken
immunoglobulin
igg
iga
antinp
elisa
kit
base
inhibitori
elisa
format
detect
kind
antibodi
bind
np
protein
present
scale
antibodi
bind
activ
np
reduct
index
npri
shown
fig
vaccin
group
significantli
higher
npri
valu
unvaccin
group
delin
mucos
antibodi
respons
induc
two
differ
form
vaccin
level
influenza
specif
igg
iga
respons
measur
laiv
iiv
vaccin
induc
signific
amount
igg
antibodi
level
induct
higher
iiv
group
laiv
group
fig
induct
iga
observ
vaccin
group
laiv
group
signific
iga
level
compar
unvaccin
group
fig
abovedescrib
data
fig
suggest
overal
laiv
iiv
stimul
immun
system
chicken
via
distinct
mechan
laiv
induc
higher
level
mucos
tear
antibodi
total
antibodi
iga
respons
fig
wherea
iiv
better
provok
system
serum
hi
mucos
igg
antibodi
respons
interestingli
neither
laiv
iiv
could
induc
high
level
serum
antibodi
usual
associ
protect
efficaci
older
bird
determin
whether
observ
immun
respons
provid
suffici
protect
heterolog
wild
type
viru
chicken
challeng
dose
heterolog
viru
volum
week
post
vaccin
week
age
level
challeng
viru
replic
trachea
compar
among
group
heterolog
base
differ
sequenc
low
crossreact
serum
hi
antibodi
tabl
dpc
median
challeng
viru
titer
unvaccin
control
group
equivalentml
signific
reduct
challeng
viru
replic
observ
iiv
group
viru
detect
one
six
bird
fig
median
challeng
viru
titer
laiv
group
log
lower
unvaccin
group
equivalentml
differ
statist
signific
expect
base
previou
studi
unvaccin
control
group
show
highest
level
challeng
viru
replic
equivalentml
dpc
although
viru
replic
significantli
reduc
vaccin
group
compar
unvaccin
group
viru
detect
half
bird
laiv
group
half
bird
iiv
group
viru
posit
median
titer
equival
ml
fig
fig
show
hi
antibodi
respons
week
age
seroconvers
bird
vaccin
day
age
iiv
laiv
agedepend
reach
homolog
viral
antigen
chicken
fig
howev
concentr
heterolog
hi
serum
antibodi
remain
either
low
level
undetect
level
fig
bird
vaccin
week
age
clear
differ
singl
vaccin
regimen
live
inactiv
vaccin
laiv
versu
iiv
one
bird
laiv
group
seroconvert
homolog
viral
antigen
post
vaccin
wpv
median
titer
reach
hi
unit
fig
time
point
three
eight
bird
iiv
group
fail
show
homolog
seroconvers
median
titer
hi
unit
fig
homolog
seroconvers
observ
bird
group
wpv
trend
median
hi
titer
revers
iiv
group
hi
unit
higher
titer
laiv
group
hi
unit
fig
result
indic
laiv
advantag
acceler
seroconvers
wherea
iiv
vaccin
induc
higher
level
antibodi
respons
chicken
vaccin
week
age
describ
although
singl
vaccin
could
induc
homolog
seroconvers
bird
week
age
wpv
iiv
laiv
wpv
laiv
iiv
induc
heterolog
seroconvers
primeboost
regimen
primari
boost
vaccin
administ
week
age
respect
tabl
postboost
vaccin
wpb
laivlaiv
laiviiv
group
show
higher
seroconvers
rate
homolog
heterolog
strain
compar
iiviiv
group
fig
perform
laiviiv
regimen
outstand
term
induc
rapid
seroconvers
highest
hi
serum
antibodi
titer
compar
group
fig
parent
viru
laivlaiv
virus
belong
north
american
lineag
show
low
crossreact
cross
hi
test
tabl
averag
hi
titer
heterolog
antigen
lower
homolog
titer
hyperimmun
sera
prepar
iiv
vaccin
use
fig
interestingli
observ
studi
differ
hi
titer
vaccin
heterolog
challeng
strain
lower
sera
group
prime
laiv
laivlaiv
laiviiv
fig
exampl
hi
titer
differ
two
strain
wpb
hi
unit
laivlaiv
group
hi
unit
laiviiv
group
wherea
hi
titer
differ
group
hi
unit
higher
except
laiv
group
hi
unit
fig
sinc
hi
titer
differ
iiviiv
group
differ
compar
iiv
singl
vaccin
iiv
iiv
reason
laivlaiv
prime
respons
broaden
reactiv
sera
thu
result
smaller
hi
titer
differ
laiviiv
laivlaiv
group
demonstr
differ
reactiv
sera
among
differ
vaccin
group
conduct
crosshi
test
calcul
percent
antigen
related
r
previous
describ
tabl
summar
antigen
related
pairwis
represent
sera
found
consist
higher
r
valu
antisera
produc
live
viru
infect
vaccin
inactiv
vaccin
tabl
r
valu
highest
laiviiv
laivlaiv
group
low
iiviiv
singl
vaccin
group
tabl
compar
level
mucos
antibodi
respons
test
tear
sampl
collect
wpb
vaccin
three
differ
elisa
describ
fig
show
group
receiv
vaccin
week
age
higher
level
total
antinp
igg
antibodi
compar
unvaccin
control
group
fig
show
vaccin
laiv
prime
booster
vaccin
result
induct
significantli
higher
level
iga
respons
compar
group
vaccin
iiv
alon
unvaccin
control
group
overal
bird
laivlaiv
group
show
consist
high
mucos
antibodi
respons
across
three
elisa
test
fig
laiviiv
group
also
show
good
level
antibodi
respons
somewhat
bias
toward
igg
respons
despit
fact
iga
respons
observ
group
significantli
differ
laiv
vaccin
group
laivlaiv
laiv
singl
vaccin
regimen
administ
week
age
iiv
laiv
show
trend
similar
vaccin
result
differ
antinp
igg
antibodi
compar
fig
fig
higher
iga
respons
laiv
group
compar
iiv
group
compar
fig
fig
data
present
clear
laiv
increas
breadth
serum
antibodi
reactiv
induc
higher
mucos
iga
respons
iiv
primeboost
regimen
use
live
inactiv
vaccin
laiviiv
result
synergist
effect
provid
highest
serum
antibodi
titer
enhanc
crossreact
serum
antibodi
high
level
tear
antibodi
respons
test
immun
respons
correl
heterolog
protect
efficaci
vaccin
regimen
viru
use
heterolog
challeng
viru
protect
efficaci
assess
term
abil
vaccin
regimen
reduc
challeng
viru
replic
trachea
compar
unvaccin
control
group
dpc
replic
challeng
viru
high
enough
enabl
comparison
protect
efficaci
among
vaccin
regimen
dpc
laiviiv
iiviiv
iiv
regimen
provid
complet
protect
heterolog
challeng
viru
laivlaiv
regimen
partial
significantli
protect
fig
reduct
challeng
viru
replic
signific
laiv
iiv
group
still
two
eight
bird
laiv
group
abl
prevent
replic
challeng
viru
fig
interestingli
laiv
regimen
significantli
protect
fig
despit
inabl
induc
heterolog
hi
antibodi
fig
low
r
valu
tabl
discov
vaccin
type
laiv
iiv
vaccin
regimen
influenti
quantiti
heterolog
crossreact
serum
hi
antibodi
fig
tabl
sought
determin
avid
antiinfluenza
viru
serum
igg
antibodi
avid
lower
younger
week
old
bird
compar
older
week
old
bird
fig
although
vaccin
type
signific
effect
serum
antibodi
avid
compar
laiv
vs
iiv
laiv
vs
iiv
laivlaiv
vs
iiviiv
avid
indic
gener
laiviiv
primeboost
regimen
stood
highest
index
fig
mani
vaccin
effect
studi
confirm
laiv
advantag
iiv
term
stimul
develop
immun
system
live
vaccin
effici
trigger
innat
immun
system
via
divers
pathogenassoci
molecular
pattern
lead
regul
sever
host
gene
includ
type
ifn
type
ifn
crucial
compon
innat
antivir
immun
system
regul
sever
hundr
isg
shape
develop
adapt
immun
respons
two
gene
oa
mx
common
among
isg
induc
type
ifn
chicken
upregul
isg
laiv
correl
well
rapid
induct
adapt
immun
respons
enhanc
protect
efficaci
chicken
interest
determin
whether
laiv
also
efficaci
younger
immunolog
chicken
evid
provid
current
studi
indic
laiv
elicit
higher
level
innat
respons
mucos
iga
antibodi
heterolog
protect
chicken
compar
iiv
addit
primeboost
vaccin
regimen
util
live
inactiv
vaccin
shown
elicit
robust
activ
system
mucos
adapt
immun
respons
provid
superior
protect
heterolog
challeng
viru
regimen
could
big
advantag
young
bird
limit
number
function
antigen
present
cell
addit
gener
advantag
live
vaccin
laiv
highli
immunogen
via
action
truncat
protein
prove
previou
studi
previous
show
abil
laiv
candid
induc
rapid
develop
adapt
immun
respons
protect
efficaci
week
old
chicken
strongli
associ
upregul
mx
gene
similar
pattern
isg
express
observ
bird
vaccin
day
age
especi
trachea
postvaccin
fig
suggest
perform
laiv
diminish
young
immunolog
immatur
chicken
induct
oa
mx
gene
upregul
trachea
also
seen
iiv
group
magnitud
lower
compar
laiv
group
fig
differ
isg
upregul
correspond
well
differ
level
mucos
iga
serum
antibodi
crossreact
protect
efficaci
induc
vaccin
isg
upregul
laiv
correspond
upregul
ifn
gene
transcript
bird
vaccin
day
age
fig
observ
previous
made
bird
vaccin
week
age
plan
investig
discrep
futur
studi
note
oral
administr
recombin
chicken
shown
mimic
laiv
induc
rapid
serum
antibodi
respons
iiv
vaccin
previou
studi
singl
administr
laiv
old
chicken
suffici
induc
signific
increas
influenza
virusspecif
iga
antibodi
tear
fail
stimul
high
serum
antibodi
titer
previou
studi
repeatedli
describ
serum
igg
mucos
iga
respons
key
featur
distinguish
live
vaccin
parenter
administ
inactiv
vaccin
protect
afford
iiv
vaccin
primarili
depend
action
neutral
serum
antibodi
serum
hi
antibodi
titer
strong
indic
iiv
efficaci
serum
antibodi
respons
alway
correl
protect
efficaci
live
vaccin
underli
mechan
serum
antibodyindepend
viral
clearanc
live
vaccin
postul
driven
mucos
iga
cell
respons
serum
antibodyindepend
viral
clearanc
util
enhanc
vaccin
efficaci
young
chicken
consid
poor
antibodi
product
abil
accord
studi
live
infecti
bronchiti
ib
viru
vaccin
chicken
differ
age
bird
vaccin
immedi
hatch
tend
produc
lower
level
serum
igg
antibodi
lower
avid
indic
compar
bird
vaccin
age
data
total
agreement
ib
studi
avid
antiinfluenza
viru
igg
agedepend
fig
avid
antibodi
induc
vaccin
age
continu
increas
bird
immun
system
matur
fig
furthermor
agedepend
igg
avid
significantli
differ
intranas
deliv
laiv
parenter
administ
iiv
fig
impli
avid
may
influenc
mode
antigen
deliveri
although
measur
avid
mucos
iga
current
studi
ib
studi
find
signific
effect
age
iga
avid
anoth
studi
live
ib
vaccin
chicken
also
show
ineffici
antibodi
respons
protect
efficaci
vaccin
mostli
correl
induct
high
level
iga
bear
b
cell
also
vaccin
day
old
chicken
adenoviru
vector
influenza
vaccin
could
induc
iga
respons
lachrym
fluid
increas
express
without
induc
detect
level
serum
antibodi
therefor
current
find
consist
previou
report
laiv
enhanc
mucos
iga
respons
provid
viral
clearanc
less
depend
serum
antibodi
respons
young
chicken
clear
differ
protect
efficaci
laiv
iiv
chicken
surpris
see
iiv
could
provid
partial
protect
fig
without
detect
level
prechalleng
heterolog
hi
antibodi
fig
consid
iiv
provid
protect
mainli
via
neutral
serum
antibodi
remain
investig
iiv
vaccin
transient
provid
almost
complet
block
viru
replic
dpc
fig
reduct
challeng
viru
laiv
vaccin
appar
dpc
statist
signific
dpc
bird
complet
protect
fig
lau
et
al
also
observ
similar
protect
trend
coldadapt
laiv
mice
challeng
heterolog
viru
dpv
signific
reduct
challeng
viru
titer
lung
observ
dpc
dpc
differ
protect
efficaci
laiv
iiv
chicken
may
reflect
differ
immunolog
mechan
protect
young
immunolog
immatur
bird
limit
capac
produc
suffici
level
serum
antibodi
believ
laiv
could
better
option
addit
optim
use
mucos
adjuv
modif
vaccin
regimen
dosag
may
improv
protect
efficaci
laiv
chicken
consid
vaccin
could
protect
bird
dpc
fig
vaccin
provid
protect
differ
mechan
reason
vaccin
could
supplement
even
synerg
use
primeboost
regimen
provid
data
prove
advantag
approach
chicken
intranas
prime
laiv
subcutan
boost
iiv
three
week
later
laiviiv
vaccin
show
rapid
robust
highli
crossreact
serum
antibodi
respons
fig
tabl
high
avid
fig
high
level
mucos
iga
respons
fig
laiviiv
regimen
remark
synergist
enhanc
crossreact
heterolog
antigen
exampl
mean
heterolog
hi
titer
induc
laiviiv
least
time
higher
mean
hi
titer
laiv
iiv
group
combin
fig
kind
synergi
live
inactiv
vaccin
previous
describ
human
talaat
et
al
found
frequenc
level
antibodi
respons
inactiv
vaccin
significantli
higher
subject
previous
prime
homolog
laiv
prime
vaccin
detect
serum
antibodi
respons
immun
system
appar
sensit
rapidli
respond
iiv
vaccin
produc
high
titer
broadli
crossreact
serum
hi
antibodi
recent
pitisuttithum
et
al
confirm
induct
high
serum
hi
antibodi
titer
iiv
laivexperienc
individu
went
demonstr
antibodi
boost
effect
correl
strongli
increas
circul
follicular
thelper
cell
plasma
b
cell
appear
longlast
prime
effect
laiv
speci
barrier
use
concept
antigen
related
base
crosshi
test
demonstr
prime
laiv
lead
induct
antibodi
enhanc
crossreact
heterolog
viru
independ
whether
boost
vaccin
live
inactiv
tabl
compar
laivlaiv
laiviiv
group
addit
antigen
related
higher
serum
produc
live
viru
infect
rel
hyperimmun
serum
produc
match
iiv
tabl
compar
column
therefor
antibodi
produc
live
viral
infect
seem
stronger
crossreact
heterolog
antigen
howev
hi
antibodi
singl
laiv
vaccin
show
enhanc
heterolog
crossreact
tabl
attribut
poor
antibodi
induct
fig
enhanc
serum
antibodi
crossreact
laiv
vaccin
live
viru
infect
report
previou
studi
jang
et
al
report
antibodi
induc
pandem
influenza
vaccin
crossreact
season
strain
hancock
et
al
found
person
year
older
serum
antibodi
crossreact
pandem
viru
sera
younger
adult
children
crossreact
author
specul
crossreact
antibodi
found
elderli
individu
result
prime
natur
infect
viru
follow
vaccin
swineorigin
vaccin
mechan
involv
induct
crossreact
antibodi
remain
investig
find
current
studi
observ
made
abovement
studi
suggest
potenti
laiv
prime
strategi
exploit
develop
broadli
effect
influenza
vaccin
regimen
three
group
receiv
iiv
week
age
laiviiv
iiviiv
iiv
develop
high
level
serum
hi
antibodi
fig
fulli
block
heterolog
challeng
viru
replic
dpc
fig
thu
effect
immunolog
advantag
laiviiv
primeboost
regimen
fig
tabl
could
resolv
level
challeng
viru
replic
full
protect
observ
group
fig
howev
laiviiv
regimen
may
best
option
field
set
circul
strain
much
distantli
relat
challeng
viru
use
studi
one
perceiv
risk
vaccin
commerci
poultri
influenza
possibl
vaccin
protect
bird
diseas
without
prevent
replic
spread
viru
demonstr
singl
dose
laiv
abl
induc
stronger
innat
mucos
iga
respons
protect
young
immunolog
immatur
chicken
better
singl
dose
convent
iiv
importantli
prime
laiv
led
synergist
serum
antibodi
induct
iiv
enhanc
antibodi
crossreact
therebi
increas
chanc
protect
distantli
relat
strain
primeboost
vaccin
strategi
requir
improv
address
possibl
limit
cost
effect
safeti
issu
addit
look
forward
evalu
efficaci
primeboost
regimen
differ
strain
hpai
virus
